跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,922 条关于
“ARO LK7”
全部
6,922
临床试验
5,912
药物
529
机构
77
资讯
404
9个月前
Arrowhead Pharmaceuticals Achieves FDA Approval for Rodemplo, Reports Strong Financial Turnaround
2年前
Arrowhead Pharmaceuticals Advances RNAi Therapies ARO-INHBE and ARO-ALK7 for Obesity Treatment
去年
Arrowhead Pharmaceuticals Launches First-in-Human Trial of ARO-ALK7 for Obesity Treatment
去年
Arrowhead Pharmaceuticals Receives $100 Million Milestone Payment for ARO-DM1 Myotonic Dystrophy Treatment
去年
Arrowhead's ARO-C3 Shows Promising Results in IgA Nephropathy Trial with 89% Reduction in C3 Levels
去年
Arrowhead Initiates Phase I/IIa Trial of RNAi Therapy ARO-INHBE for Obesity
11个月前
Aro Biotherapeutics Completes Enrollment in Phase 1b Trial of Novel siRNA Therapy for Late-Onset Pompe Disease
去年
Aro Biotherapeutics' ABX1100 Receives FDA IND Clearance for Late-Onset Pompe Disease Trial
去年
Arrowhead Pharmaceuticals Advances Two Breakthrough RNAi Therapeutics into Clinical Trials
8个月前
Arrowhead's Gene-Silencing Drugs Show Promise in Early Obesity Studies, Enhancing Weight Loss When Combined with Zepbound
第 1 页,共 41 页
上一页
下一页